Evidence map›Paper›PMID 41185394›Full record

GuidelineAndrology2026

Recommendations for Human Sperm Morphology Assessment in 2025: An Expert Review From the French BLEFCO Group.

Nicolas Gatimel, Anne-Laure Barbotin, Lionel Mery, Damien Beauvillard, Marion Bendayan, Angèle Boursier, Thomas Boueilh, Bruno Pereira, Jérémy Chammas, Jean-Claude Jacquet and 5 more

Abstract readPractice GuidelineReview
In one paragraph

Guideline in Andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nicolas GatimelDepartment of Reproductive Medicine, Hôpital Paule de Viguier, CHU De Toulouse, Toulouse, France.
Anne-Laure BarbotinBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Lionel MeryBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Damien BeauvillardBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Marion BendayanBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Angèle BoursierBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Thomas BoueilhBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Bruno PereiraBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Jérémy ChammasBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Jean-Claude JacquetBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Rachel LevyBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Jérôme PfefferBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Hanae Pons-RejrajiBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Pierre SanguinetBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.
Florence BrugnonBLEFCO, French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L'œuf, Labège, France.

Funding

Fédération nationale des Biologistes des Laboratoires d'Étude de la Fécondation et de la Conservation de l'Œuf (BLEFCO)
6 · The paper itself

Abstract

backgroundNumerous publications have questioned the lack of analytical reliability and clinical relevance of sperm morphology assessment for infertility workup and before use of assisted reproductive techniques (ART). There is a huge variability in the performance and interpretation of this test. It has become necessary to evaluate its true medical service rendered to the patient.

objectivesTo develop clinical guidelines for use of spermatozoa morphology assessment during male fertility check-up and before ART. MATERIALS AND

methodsThese guidelines were produced following a pre-defined standard methodology for narrative and Patient Intervention Comparison Outcomes (PICO) questions. The French Working Group (WG) on Sperm Morphology Assessment consisted of 15 members including an expert in statistics.

resultsR1: WG does not recommend systematic detailed analysis of abnormalities (or groups of abnormalities) during sperm morphology assessment. R2: WG recommends that the laboratory should use a qualitative or quantitative method for detection of a monomorphic abnormality (globozoospermia, macrocephalic spermatozoa syndrome, pinhead spermatozoa syndrome, multiple flagellar abnormalities). The result may be given as an interpretative commentary or as a numerical report of the percentage of detailed abnormalities. R3: There is insufficient evidence to demonstrate the clinical value of indexes of multiple sperm defects (TZI, SDI, MAI) in investigation of infertility and before ART. Accordingly, the working group does not recommend the use of sperm abnormality indexes (TZI, SDI, MAI) in sperm morphology assessment. R4: WG gives a positive opinion on the use of automated systems based on cytological analysis after staining after qualification of the operators, and validation of the analytical performance within their own laboratory. R5: WG does not recommend using the percentage of spermatozoa with normal morphology as a prognostic criterion before IUI, IVF, or ICSI, or as a tool for selecting the ART procedure. DISCUSSION: This article examines the clinical interest of sperm morphology assessment during fertility check-up and before ART. The overall level of evidence from studies is low, challenging current practices regarding sperm morphology assessment.

conclusionThese guidelines suggest a significant simplification of sperm morphology assessment in the light of the examined publications while maintaining the detection of monomorphic sperm abnormalities.

Indexed as

Infertility, MaleSemen AnalysisSpermatozoaFranceHumansMaleARTclinical guidelinesICSIIVFmale infertilitysperm morphology

Identifiers

PMID41185394
PMCPMC12670483

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.